Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Melanoma | D008545 | — | — | 20 | 23 | 3 | — | 1 | 39 |
Non-small-cell lung carcinoma | D002289 | — | — | 14 | 24 | 3 | — | — | 30 |
Neoplasms | D009369 | — | C80 | 26 | 17 | 1 | — | 1 | 30 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 8 | 6 | 1 | — | — | 13 |
Squamous cell carcinoma of head and neck | D000077195 | — | — | 5 | 8 | 1 | — | — | 12 |
Renal cell carcinoma | D002292 | EFO_0000376 | — | 8 | 7 | 1 | — | — | 12 |
Lung neoplasms | D008175 | — | C34.90 | 5 | 8 | 1 | — | — | 11 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 4 | 6 | 1 | — | — | 8 |
Head and neck neoplasms | D006258 | — | — | 4 | 4 | 1 | — | — | 7 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | 2 | 4 | 1 | — | — | 7 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 10 | 10 | — | — | — | 14 |
Colorectal neoplasms | D015179 | — | — | 9 | 8 | — | — | — | 12 |
Glioblastoma | D005909 | EFO_0000515 | — | 6 | 2 | — | — | — | 7 |
Colonic neoplasms | D003110 | — | C18 | 3 | 5 | — | — | — | 6 |
Cutaneous malignant melanoma | D000096142 | — | — | 3 | 3 | — | — | — | 6 |
Adenocarcinoma | D000230 | — | — | 2 | 4 | — | — | — | 5 |
Prostatic neoplasms | D011471 | — | C61 | 2 | 5 | — | — | — | 5 |
Glioma | D005910 | EFO_0000520 | — | 3 | 3 | — | — | — | 5 |
Transitional cell carcinoma | D002295 | — | — | 5 | 2 | — | — | — | 5 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 4 | 4 | — | — | — | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Urinary bladder neoplasms | D001749 | — | C67 | 3 | — | — | — | — | 3 |
Glandular and epithelial neoplasms | D009375 | — | — | 2 | — | — | — | — | 2 |
Myoepithelioma | D009208 | — | — | 2 | — | — | — | — | 2 |
Hepatitis c | D006526 | — | B19.2 | 1 | — | — | — | — | 1 |
Hepatitis | D006505 | — | K75.9 | 1 | — | — | — | — | 1 |
Hepatitis a | D006506 | EFO_0007305 | B15 | 1 | — | — | — | — | 1 |
Multiple myeloma | D009101 | — | C90.0 | 1 | — | — | — | — | 1 |
Neoplasms by histologic type | D009370 | — | — | 1 | — | — | — | — | 1 |
Urinary bladder diseases | D001745 | — | N32.9 | 1 | — | — | — | — | 1 |
Astrocytoma | D001254 | EFO_0000271 | — | 1 | — | — | — | — | 1 |
Drug common name | Gilvetmab |
INN | gilvetmab |
Description | Gilvetmab is an antibody pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL3990007 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 949NG8376D (ChemIDplus, GSRS) |